Teduglutide

GutFDA-approved

Also known as: Gattex

A GLP-2 analog for short bowel syndrome.

Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.

How it works

Grows the absorptive lining of the intestine, so patients need less IV nutrition.

Evidence by goal

GoalGradeWhat the grade means
Gut healthAApproved for this use or large randomized trials

At a glance

Route
Subcutaneous daily
Half-life
About 2 hours

Reported dosing

0.05 mg/kg once daily.

Timing: Once daily, any time.

Cycle: Ongoing, with regular colonoscopy.

From approved labels where they exist, otherwise from published trials and practitioner reports.

Side effects

  • Abdominal pain, swelling at stoma
  • Risk of intestinal polyps and growth of existing tumors

Who should avoid it

  • Active GI cancer

Often combined with

Alone.

Key findings

Reduced need for parenteral nutrition by 20% or more in most trial patients.

Where it is legal (Oct 2026)

USPrescription
CanadaPrescription
MexicoVerify locally
EUPrescription

Sources

Open Teduglutide in the Peptide Guide Compare all peptides by goal

Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.

Natoorales and e4life.io (Mexico residency and immigration help) are sister businesses founded by Ian Kain.

Scroll to Top